Mustafa Tosur, MD, FAAP
- Diabetes and Endocrinology
Director, Monogenic Diabetes Center
Pediatric Endocrinologist
Associate Professor of Pediatrics, Division of Endocrinology and Diabetes, Baylor College of Medicine
Phone:
832-822-3670
Languages: English, Turkish
Departments:
Office location:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Mustafa Tosur, MD, FAAP
Personal Statement
I am a board-certified Pediatric Endocrinologist and Physician-Scientist, Associate Professor of Pediatrics at Baylor College of Medicine, and Director of the Monogenic Diabetes Center at Texas Children's Hospital. I care for children with all forms of diabetes and endocrine conditions, with special expertise in monogenic diabetes (MODY), youth-onset type 2 diabetes, and rare and atypical forms of diabetes. My goal is to give every child an accurate diagnosis and the treatment that fits them best. I want every family to get the compassionate, state-of-the-art care I would want for my own family. Alongside patient care, I lead research on why diabetes differs from child to child, and I train the next generation of pediatricians and endocrinologists.
Clinical Interests
My clinical interests include:
Pediatric diabetes: monogenic diabetes (MODY), youth-onset type 2 diabetes, type 1 diabetes, and rare and atypical diabetes
Congenital hyperinsulinism and hypoglycemia
General endocrinology: growth, thyroid, puberty, adrenal, and calcium disorders
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor College of Medicine | Certification | Certificate of Added Qualification in Clinical Investigation | 2020 |
| Baylor College of Medicine | Fellowship | Pediatric Endocrinology | 2018 |
| The University of Texas Medical Branch | Residency | Pediatrics | 2015 |
| Hacettepe University - Turkey | Medical School | Doctor of Medicine | 2011 |
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics | Fellow (FAAP) |
| American Diabetes Association | Member |
| Precision Diabetes Consortium (PREDICT) – Monogenic Data Commons | Executive Committee Member; Site Director |
| Rare and Atypical Diabetes Network (RADIANT) | Co-Chair, Discovery Team Phenotypers & Clinicians Group; Adjudication Committee |
| Society for Pediatric Research | Member |
| Type 1 Diabetes TrialNet Site | Principal Investigator |
Board Certifications
| Title |
|---|
| American Board of Pediatrics - Pediatrics |
| American Board of Pediatrics – Pediatric Endocrinology |
Honors and awards
- 2026
-
Outstanding Abstract Award, Nutritional Science & Metabolism Interest Group, American Diabetes Association
- 2025
-
Outstanding Abstract Award, Nutritional Science & Metabolism Interest Group, American Diabetes Association
- 2025
-
Research Mentor Champion for Medical Students, SOAR Office, Baylor College of Medicine
- 2022-2027
-
K23 Early Career Award, The National Institute of Health
- 2022
-
Ambulatory Practitioner Award for Excellence in Patient Experience (Silver, Bronze, and Red Pin), Texas Children's Hospital
- 2019-2022
-
Pediatric Pilot Award, Texas Children's Hospital
- 2019-2022
-
Mike Hogg Foundation Award
- 2021-2022
-
"Caught You Caring" Patient Recognition for Going Above and Beyond, Texas Children's Hospital
- 2021
-
Outstanding Abstract Award, Diabetes Nutritional Science & Metabolism Interest Group, American Diabetes Association
- 2018
-
Early Career Award, Endocrine Society
- 2017-2018
-
Chief Fellow, Pediatric Endocrinology, Texas Children's Hospital/Baylor College of Medicine
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Reviews
Research interests
My research studies how genetics, metabolism, and race/ethnicity cause pediatric diabetes to differ in how it presents, progresses, and responds to treatment. Current areas of focus:
- Monogenic diabetes including MODY (maturity-onset diabetes of the young)
- Youth-onset type 2 diabetes and prediabetes
- Rare and atypical diabetes, including ketosis-prone diabetes
- Type 1 diabetes: screening, staging, and prevention
- Artificial intelligence and EHR-based methods for precision medicine in pediatric diabetes
Tobias DK*, Merino J*, Tosur M*, Wallace AS*, Wang CC*, Wong JJ*, Sherr JL*, Sims EK*, Sweeting A*, Tuomi T*, Udler MS*, Vesco KK*, Vilsbøll T*, Wagner R*, Rich SS*, Franks PW* et al. Second International Consensus Report on Gaps and Opportunities for the Clinical Translation of Precision Diabetes Medicine. Nature Medicine, 2023 Oct;29(10):2438-2457. Epub 2023 Oct 5. *Contributed equally
Tosur M, Hsu JW, Deen S, Huang X, Guffey D, Uysal S, Astudillo M, Redondo MJ, Jahoor F and Balasubramanyam A. Plasma amino acid signatures define types of pediatric diabetes. Clinical Nutrition ESPEN, June 2023, Online ahead of print
Tosur M, Gandolfo L, Balasubramanyam A, Naylor RN, Pollin TI, Rasouli N, Cromer SJ, Buse JB, Redondo MJ, RADIANT Study Group. Enrollment of Underrepresented Racial and Ethnic Groups in the Rare and Atypical Diabetes Network (RADIANT). Journal of Clinical and Translational Science. 2023 Jan 23; 7(1):e47
Tosur M, Phillipson LH. Precision Diabetes: Lessons Learned from Maturity-Onset Diabetes of the Young (MODY). Journal of Diabetes Investigation. 2022, Sep; 13(9)1465-1471
Tosur M, Soler-Alfonso C, Chan KM, Khayat MM, Jhangiani SN, Meng Q, Refeay A, Muzny D, Gibbs RA, Murdock DR, Posey J, Balasubramanyam A, Redondo MJ, Sabo A. Exome Sequencing in Children with Clinically Suspected Maturity-Onset Diabetes of the Young. Pediatric Diabetes. 2021 Nov; 22(7): 960-968
Tosur M, Cleves M, Sosenko J, Libman I, Baidal D, Balasubramanyam A, Redondo MJ. The Effect of Ethnicity in the Rate of Beta Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis. Journal of Clinical Endocrinology and Metabolism. 2020, Dec 1; 105(12):e4393-406
Tosur M, Rodriguez H, Libman I, Baidal D, Redondo MJ. Ethnic Differences in Progression to Type 1 Diabetes in Relatives at Risk. Diabetologia. 2018 Sep; 61(9):2043-2053